ARCHIVES

More Bad News for AVEO As Tivozanib Partner Bids Adieu

This article is from The Cancer Letter archive.

Vol. 39 No. 22 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Two Phase III Afatinib Trials Demonstrate Prolonged Survival

May 30, 2014

Scientists, Public Citizen Urge FDA To Ban Sale Of Obesity Drug Orlistat.

June 2, 2006

In Brief: Search Committee Could Finish Job Weeks, Perry Says Nominations Are Being Solicited

January 11, 1980

AIDS Patients Face Higher Risk Of HPV-Related Cancers As Immunosuppression Grows

August 28, 2009

GAO Criticize NCI Contract Practices In Report On Cancer Control

July 25, 1980

Letters to the Editor: Burzynski: Reviewers Sought To Discredit Antineoplaston Therapy

October 30, 1998